98433749 - BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Information

• Trademark
• 98433749

• Source

• Serial Number

  98433749

• International Classifications

  • 44 - Medical services

• Filing Date

  March 05, 2024
  9 months ago

• Transaction Date

  December 11, 2024
  7 days ago

• Status Date

  December 10, 2024
  8 days ago

• Published for Opposition Date

  December 31, 2024
  12 days from now

• Location Date

  December 10, 2024
  8 days ago

• First Use Anywhere Date

  December 28, 2022
  a year ago

• First Use In Commerce Date

  December 28, 2022
  a year ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  WOLFE, YOUNG

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  N40

• Owners

  • TG THERAPEUTICS, INC

Case File Statements

• DM0000: The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold.
• PM0002: BRIUMVI UBLITUXIMAB XIIY ONE HUNDRED FIFTY MG PER SIX ML INJECTION FOR IV
• PM0001: BRIUMVI UBLITUXIMAB XIIY ONE FIVE ZERO MG PER SIX ML INJECTION FOR IV
• CC0000: The color(s) black, dark grey, light blue and gold is/are claimed as a feature of the mark.
• GS0441: Providing health information
• DS0000: "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV"
• TR0000: The wording BRIUMVI has no meaning in a foreign language.

Case File Event Statements

• 3/5/2024 - 9 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 7/18/2024 - 5 months ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 7/18/2024 - 5 months ago

  4 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 7/18/2024 - 5 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/18/2024 - 3 months ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 9/23/2024 - 2 months ago

  8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/23/2024 - 2 months ago

  7 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/3/2024 - 15 days ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/3/2024 - 15 days ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/3/2024 - 15 days ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/5/2024 - 13 days ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/23/2024 - 2 months ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT